BAL PHARMA
|
The Current P/S Ratio of BAL PHARMA is 0.40.
| Share Price | ₹79.1 | Jul 07,2026 |
| Market Cap | ₹125.7 Cr | |
| Sales-TTM | ₹311.7 Cr | TTM-Consolidated Results |
| Price/Sales | 0.40x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹125.7 Cr] as on Jul 07,2026
(/) Sales [ ₹311.7 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 0.40x ]
Thus, for BAL PHARMA , the investors are currently willing to pay '0.40 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAL PHARMA !
The chart below summarizes the trend in P/S Ratio of BAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of BAL PHARMA
PS Ratio Performance Analysis for BAL PHARMA
- BAL PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.42x.
- BAL PHARMA 's operated at median p/e ratio of 0.43x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAL PHARMA 's p/e ratio peaked in Mar2022 at 0.57x.
- BAL PHARMA 's p/e ratio hit its five-year low in Mar2021 of 0.32x.
How does BAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BAL PHARMA | 311.7 | 0.40 | 125.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.81 | 456,593.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 17.02 | 179,737.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.75 | 164,290.0 |
| CIPLA LTD | 28,162.6 | 4.17 | 117,327.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.35 | 112,994.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.32 | 104,550.0 |
| LUPIN LTD | 27,958.0 | 4.07 | 113,844.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.24 | 115,002.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.71 | 91,082.3 |
| LAURUS LABS LTD | 6,812.9 | 11.71 | 79,784.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAL PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 0.40x |
| Max industry PS | 17.02x |
| Median industry PS | 4.24x |
| Average industry PS | 6.78x |
You may also like the below Video Courses